Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanomicellar curcumin in metabolic syndrome
IRCT20150815023617N4Phase 3Completed
- Sponsor
- National Nutrition and Food Technology Research Institute
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of curcumin in cardiometabolic risk (CMR), sponsored by National Nutrition and Food Technology Research Institute. Started May 2018; status: completed.
02
Drugs
curcumin
03
Conditions
cardiometabolic risk (CMR)
Beyond the preview
Go deeper on IRCT20150815023617N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150815023617N4.